Event Type: | Date: mai 18, 2022 - mai 19, 2022 | Location: Paris Expo, Porte de Versailles, Paris, France

Pharmapack 2022

STERIS will be attending Pharmapack 2022 at Paris Expo, Porte de Versailles, Paris, France on Wednesday 18 and Thursday 19 May 2022.

Attendees are invited to visit us at Stand D18 in Hall 7.2.

Find out more on the Pharmapack website.

Learning Lab

STERIS will be delivering three presentations at the Learning Lab:

Testing Requirements for Sterile Barrier Packaging and Devices
Wednesday 18 May 2022, 10.10 hrs – 10.40 hrs. Presented by Noel Gibbons, Technical Advisor-Packaging, STERIS Applied Sterilization Technologies.

  • Transportation testing, accelerated aging and package integrity testing overview.
  • How to construct a packaging validation protocol.
  • What new requirements are there for the recent releases of ASTM F1980 and ASTM D4169?
  • Device test considerations.

Radiation Technology Transfer Methodology
Thursday 19 May 2022, 10.10 hrs – 10.40 hrs. Presented by Pierre Reppert, Validation Manager, STERIS Applied Sterilization Technologies.
This session will describe the methodology for transferring the sterilization process of medical or pharma products from one radiation technology to another (e.g. gamma to X-ray).

Considerations for Drug Delivery Device Primary and Secondary Packaging with Vaporized Hydrogen Peroxide Terminal Sterilization
Thursday 19 May 2022, 12.10 hrs – 12.40 hrs. Presented by Juha Mattila, Director Sterilization Technologies, STERIS Life Sciences.
VHP sterilization is a viable alternative for ensuring improved patient safety by providing a sterile product application for drug delivery devices, such as pre-filled syringes with temperature or radiation sensitive drug products, that are too sensitive for conventional methods of sterilization.
Material selections, device design, properties of the pre-filled syringe, and secondary packaging decisions (shape, materials) play an important role in ensuring the sterilization process is successful.
The major things to avoid are known in the industry, but there are more opportunities for proactively preparing for this in advance, during the design phase, when making considerations for the intended sterilization method – for example – thinking about applying the IPCD (internal process challenge device and EPCD (external process challenge device) in good time beforehand.
These are key considerations when aiming at short lead-time product-to-market strategy – from sterilization perspective. This presentation looks at these from this viewpoint.

Register